International Patent: MUC1-C AS A TARGET FOR CANCER TREATMENT

GENEVA, Oct. 30 -- DANA-FARBER CANCER INSTITUTE, INC. filed a patent application (US2026/024669) for “MUC1-C AS A TARGET FOR CANCER TREATMENT”. With publication no. WO/2026/226647, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/501

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....